Wall Street’s Key Stock Analysts Research Reports, All Buys
#stocks #bullish #buys #analysts #research #WallStreet
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Tuesday, 6 July, as follows:
BRP Inc. (NASDAQ:DOOO): Raymond James started coverage with a Strong Buy rating. The stock closed Friday at 79.42, within its 52-wk range of 40.03 - 96.44.
Harrow Health Inc. (NASDAQ:HROW): Ladenburg Thalmann initiated coverage with a Buy rating and a 14.25 price target. The stock trades in a 52-week range of 4.65 - 11.24.
Renalytix PLC (NASDAQ:RNLX): Berenberg initiated coverage with a Buy rating and a 38 price target. Shares closed Friday at 28,20 and the 52-wk range is 9.91 - 35.71.
Have a prosperous week, Keep the Faith!
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Larry Fink Called It. CME Just Made It Real. The Compute Futures Market Has Arrived
The Quantum-AI Convergence Is Real. The Quantum Stocks Aren't the Trade.
China’s Economic Resilience
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.